Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,863,294
-
Total 13F shares
-
80,869,592
-
Share change
-
+307,652
-
Total reported value
-
$1,591,453,895
-
Put/Call ratio
-
155%
-
Price per share
-
$19.68
-
Number of holders
-
193
-
Value change
-
+$4,936,347
-
Number of buys
-
81
-
Number of sells
-
94
Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q3 2021
As of 30 Sep 2021,
CORCEPT THERAPEUTICS INC - Common Stock (CORT) was held by
193 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,869,592 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, INGALLS & SNYDER LLC, FEDERATED HERMES, INC., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, Parallel Advisors, LLC, and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP.
This page lists
193
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.